Literature DB >> 3882857

The relation of the Ibc protein antigen to the opsonization differences between strains of type II group B streptococci.

N R Payne, P Ferrieri.   

Abstract

Thirty-one type II and eight nontypable group B streptococcal isolates were categorized by the presence of the trypsin-resistant and trypsin-sensitive components of the Ibc protein antigen and studied for opsonization differences by using polymorphonuclear leukocyte chemiluminescence (CL). Type II strains varied in their ease of opsonization: strains possessing both components of the Ibc protein elicited a significantly lower mean CL peak (P less than or equal to .05) and a smaller CL integral (P less than or equal to .01) than did type II strains lacking both components or strains lacking type polysaccharide antigen but possessing the Ibc protein antigen. These strain differences were seen consistently with different sera and were also observed in an opsonophagocytic killing assay. Differences in opsonizing ability and bacterial killing were found for three standard test sera but could not be related to the concentration of type-specific antibody to capsular polysaccharide antigen. Our studies suggested that the Ibc protein antigen was one factor that contributed to the resistance to opsonization of strains of type II group B streptococci.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882857     DOI: 10.1093/infdis/151.4.672

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  High expression of a C protein beta antigen gene among invasive strains from certain clonally related groups of type Ia and Ib group B streptococci.

Authors:  Noriyuki Nagano; Yukiko Nagano; Fumiaki Taguchi
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  Influence of serotype of group B streptococci on C3 degradation.

Authors:  J R Campbell; C J Baker; M S Edwards
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

3.  Opsonic effect of jacalin and human immunoglobulin A on type II group B streptococci.

Authors:  N R Payne; N F Concepcion; B F Anthony
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

4.  Nonimmune binding of human immunoglobulin A to type II group B streptococci.

Authors:  B F Anthony; N F Concepcion; S M Puentes; N R Payne
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

5.  Molecular species of R-protein antigens produced by clinical isolates of group B streptococci.

Authors:  A E Flores; P Ferrieri
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

6.  bca, beta gene, and gene product divergency in reference and prototype strains of streptococcus agalactiae.

Authors:  J A Maeland; L Bevanger; G Iversen; R V Lyng
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

7.  Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity.

Authors:  J L Michel; L C Madoff; D E Kling; D L Kasper; F M Ausubel
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

8.  Molecular analysis of multiple isolates of the major serotypes of group B streptococci.

Authors:  E Fasola; C Livdahl; P Ferrieri
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

9.  Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci.

Authors:  Sezgin Erdogan; Peter K Fagan; Susanne R Talay; Manfred Rohde; Patricia Ferrieri; Aurea E Flores; Carlos A Guzmán; Mark J Walker; Gursharan S Chhatwal
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

10.  Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococci.

Authors:  N R Payne; Y K Kim; P Ferrieri
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.